HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...
Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate ...
FibroBiologics (FBLG) announced the filing of a Phase 1/2 Investigational New Drug application with the U.S. Food and Drug Administration seeking regulatory clearance to initiate clinical trials of ...
Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON (IMNN), Inc. ...
Indiana’s rural health transformation proposal outlines a multi-year plan to build new health partnerships, redesign primary care and strengthen rural hospital operations — all with help from federal ...
Indiana’s application for a share of the federal government’s $50 billion Rural Health Transformation Program lays out a sweeping, multi-year plan to stabilize struggling hospitals, expand essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results